X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Lipids in Health and Disease

期刊標題檢索 LIPIDS HEALTH D 最新評論: I waited for four months without any progress, and even sent a reminde... (2024-10-21)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Lipids in Health and Disease]您好,您是該頁面的第 65978 位訪客。

期刊簡介
期刊名稱Lipids in Health and Disease Lipids in Health and Disease
LetPub Score
6.6
50 ratings
Rate

Reputation
7.3

Influence
5.4

Speed
9.0

期刊簡稱LIPIDS HEALTH DIS
ISSN1476-511X
h-index57
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.701.1121.220
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q154 / 244
Category: Medicine
Subcategory: Biochemistry (medical)
Q117 / 72
Category: Medicine
Subcategory: Endocrinology
Q234 / 128
Category: Medicine
Subcategory: Clinical Biochemistry
Q232 / 117

自引率 (2023-2024)2.60%自引率趨勢
掲載範囲
Lipids in Health and Disease is an open access, peer-reviewed, journal that publishes articles on all aspects of lipids: their biochemistry, pharmacology, toxicology, role in health and disease, and the synthesis of new lipid compounds.

Lipids in Health and Disease is aimed at all scientists, health professionals and physicians interested in the area of lipids. Lipids are defined here in their broadest sense, to include: cholesterol, essential fatty acids, saturated fatty acids, phospholipids, inositol lipids, second messenger lipids, enzymes and synthetic machinery that is involved in the metabolism of various lipids in the cells and tissues, and also various aspects of lipid transport, etc. In addition, the journal also publishes research that investigates and defines the role of lipids in various physiological processes, pathology and disease. In particular, the journal aims to bridge the gap between the bench and the clinic by publishing articles that are particularly relevant to human diseases and the role of lipids in the management of various diseases.
官方網站http://lipidworld.biomedcentral.com
在線稿件提交https://submission.nature.com/new-submission/12944/3
開放訪問Yes
出版商BioMed Central
主題領域生物
出版國/地區ENGLAND
發行頻率月刊
創刊年2002
每年文章數212每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( GBP2190; USD2890; EUR2390; )
APC waiver:Check Notes
Other charges: No
Keywords: lipid biochemistry、lipid synthesis、pharmacology、toxicology、lipid metabolism
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ2104/313
NUTRITION & DIETETICSSCIEQ232/114
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-511X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Lipids in Health and Disease】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular CancerH-index: 103

    CiteScore: 54.90
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 24.70
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1332312
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS575324
    JOURNAL OF BIOLOGICAL CHEMISTRY396195
    NUCLEIC ACIDS RESEARCH341827
    CELL298590
    FASEB JOURNAL270762
    International Journal of Biological Sciences241058
    PLANT SCIENCE228327
    Molecular Cancer228106
    ONCOGENE203904
  •  

    Lipids in Health and Disease Lipids in Health and Disease
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/10)
  [Lipids in Health and Disease] 的評論撰寫評論
作者: Mr行则将至


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-21 21:42:41 評論於
I waited for four months without any progress, and even sent a reminder email midway but got no response. Then yesterday, I received feedback from only one reviewer, just two short sentences with no substantive comments, and my paper was rejected. Four months wasted like this, what a joke!
(0) 讚! | Mr行则将至

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-19 15:03:45 評論於
From proofreading to the publication of the article, it usually takes about a week.
(0) 讚! | Adelaide Lawson

作者: 邻家青枫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-19 13:29:28 評論於
What happened later? Has it been submitted for review? And about how long did it take to be submitted for review?
(0) 讚! | 邻家青枫

作者: 天山馨香


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-15 13:25:23 評論於
How long?
(0) 讚! | 天山馨香

作者: 田ttttt


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-14 09:47:46 評論於
I would like to ask, I submitted my manuscript using the account of Da Tongxun, and also selected her as the corresponding author. The order of other authors is correct, but when I received the email, Da Tongxun was placed in the first author position. I want to ask if this is the case on your end, or if I really made a mistake.
(0) 讚! | 田ttttt

作者: 书容公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-13 19:46:28 評論於
Like me.
(0) 讚! | 书容公子

作者: Josephine Sherwood


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-09 13:15:34 評論於
How soon after proof can we expect to see the publication?
(0) 讚! | Josephine Sherwood

作者: Adela Marion


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-10 15:33:42 評論於
How long?
(0) 讚! | Adela Marion

作者: JWonderce


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-09-10 13:14:17 評論於
This journal must be perfect, it's a matter of life and death for me. The major revisions were accepted in just two months, although there was a requirement for a 10% similarity check and proofreading. I only managed to reduce it to 14%, but after explaining the reasons to the editor, it was understandable. I found the cheapest proofreading service that could provide an international proofreading certificate, even though the proofreading quality was only average.
(1) 讚! | JWonderce

作者: Troy Wilde


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-06 23:55:44 評論於
Review speed: 3.0 | Submission hit rate: 25.0 Experience sharing: The editor first returned the submission for polishing, then checked for plagiarism, and after resubmission, found two reviewers, both of whom provided some irrelevant comments. One of them raised a sharp issue, stating that the statistical method was problematic. I responded to the questions point by point, added several references supporting this method and my research, and eventually passed the revision. Although it was successful, the process of submission, review, and revision was very exhausting.
(0) 讚! | Troy Wilde

作者: lulobule


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-03 13:58:37 評論於
Did you find a new reviewer only after the rejection and resubmission? However, I also invited 5 reviewers after major revisions, and I am not sure if the original reviewer will be invited again.
(0) 讚! | lulobule

作者: 凌霄春磊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-28 09:38:21 評論於
Review speed: 1.0 | Submission hit rate: 25.0 
Research direction with emphasis: animal experiments; lipid metabolism 
Sharing of experience: rejected twice, hard to say, submitted on 23 April 2024, sent for review on the same day, received feedback in 2 weeks. One reviewer raised many experimental and article-related questions, over a dozen in total, but none were fatal. It was feasible to make improvements by conducting additional experiments and revising the discussion. The feedback was for major revisions. The second reviewer mainly pointed out formatting and language issues, but surprisingly, the feedback was a rejection, requesting revisions and image changes. 
On 2 May 2024, the final decision from the editor was to reject the submission for resubmission with revisions, reduced content, improvements in language, submission of plagiarism and revision certificates, and point-to-point responses to the issues raised. After much hesitation, it took a month to conduct additional experiments, revise, and check for plagiarism. The effort and money spent need not be mentioned. On 8 June 2024, the revised submission was made, and on 9 June 2024, the editor requested the upload of the original, untrimmed WB images. These were uploaded on 11 June 2024, passed the technical review on 12 June 2024, and sent for review on 13 June 2024, with five new reviewers being assigned. 
On 9 July 2024, all feedback was received, with opinions from four reviewers - one positive, two neutral, and one negative. Over 50 points were raised in total. The editor directly rejected the submission. If you are going to reject it, do it decisively. After being dragged through this process for two months and spending money, being rejected at the end, I will definitely not submit again next time. The feedback was not even returned to the original reviewers, making me wonder about the purpose of resubmission and revisions.
(0) 讚! | 凌霄春磊

作者: 艾去西西


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-22 03:35:30 評論於
I invited 15 reviewers on August 5th, and now it's August 22nd with no changes.
(0) 讚! | 艾去西西

作者: 八荒沛白


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-05 12:40:43 評論於
Hello, may I ask if the editor has polished your language? Do you have to use their own language editing, or can I just find a company to do the polishing?
(0) 讚! | 八荒沛白

作者: 红云小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-02 23:34:36 評論於
Just submitted my work, feeling lucky.
(0) 讚! | 红云小公主

作者: Mr行则将至


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-20 22:05:40 評論於
On June 23rd, invitations were sent to 40 reviewers, but the status has remained unchanged since then. Have reviewers not been found yet?
(0) 讚! | Mr行则将至

作者: zaker


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-01 23:53:12 評論於
May I ask how long it takes for you to receive the feedback for the second review? I have also re-invited three reviewers.
(0) 讚! | zaker

作者: 魔都玉航


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-01 09:23:19 評論於
Are you also required to reduce weight after major repairs?
(0) 讚! | 魔都玉航

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-28 12:39:49 評論於
This has no practical significance, it is just a formality check.
(0) 讚! | 是志丹吖

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-28 10:46:19 評論於
Polishing alone does not guarantee acceptance. In general, it is best to first revise the submission for quality before polishing, as this can address language issues and improve the overall quality. Otherwise, just polishing without revising the content may lead to grammar issues when making changes later.
(0) 讚! | 是志丹吖

作者: 稻妻宏帅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-27 09:12:16 評論於
I spent money to polish it, but the result was rejected again.
(0) 讚! | 稻妻宏帅

作者: 波小慧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-15 22:14:25 評論於
Does the similarity check have to be within 10%? I have revised it three times, checked for similarity three times, and it is still at 18%
(0) 讚! | 波小慧

作者: 书容公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-12 23:49:27 評論於
Review speed: 6.0 | Submission success rate: 50.0 Experience sharing: Submitted in August of Year 23, received first revision in March of Year 24, with three reviewers during the process. The first and second reviewers requested one revision, while the third reviewer requested four revisions. The editor requested one revision. Accepted in June of Year 24. A total of 10 months.
(0) 讚! | 书容公子

作者: 凌霄春磊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-10 21:31:16 評論於
During the technical review, I requested to submit untrimmed full films into the support material.
(0) 讚! | 凌霄春磊

作者: 凌霄春磊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-10 16:42:28 評論於
BMC should require all of its subsidiaries to do so.
(0) 讚! | 凌霄春磊

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/10)

開始撰寫 [Lipids in Health and Disease] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*